TickerFactsScreenerDevelopers

NEOGENOMICS INC (NEO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $1.63M2010: $1.10M2011: $2.63M2012: $1.87M2013: $4.83M2014: $33.69M2015: $23.42M2016: $12.53M2017: $12.82M2018: $9.81M2019: $173.02M2020: $228.71M2021: $316.83M2022: $263.18M2023: $342.49M2024: $367.01M2025: $159.62M$159.62M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$159.62M-56.5%
2024$367.01M+7.2%
2023$342.49M+30.1%
2022$263.18M-16.9%
2021$316.83M+38.5%
2020$228.71M+32.2%
2019$173.02M+1663.5%
2018$9.81M-23.5%
2017$12.82M+2.4%
2016$12.53M-46.5%
2015$23.42M-30.5%
2014$33.69M+596.9%
2013$4.83M+158.8%
2012$1.87M-28.9%
2011$2.63M+139.6%
2010$1.10M-32.7%
2009$1.63M—